Axel Bouchon
Vorstandsvorsitzender bei AMLOne UG (haftungsbeschränkt)
Aktive Positionen von Axel Bouchon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01.12.2021 | - |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - | - |
Brain Games Corp. | Vorsitzender | 01.01.2020 | - |
AMLOne UG (haftungsbeschränkt) | Vorstandsvorsitzender | 01.07.2016 | - |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Matter Neuroscience is an American company that develops mobile applications for neurological reward systems. The private company was founded by Benjamin Goldhirsh and Axel Bouchon, with Axel Bouchon serving as the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2019 | - |
Gründer | 01.01.2019 | - |
Karriereverlauf von Axel Bouchon
Ehemalige bekannte Positionen von Axel Bouchon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology BrainLuxury, Inc. is a company that provides natural alternatives for deep sleep and focus, driven by science. The company is based in New York, NY. The company's mission is to nourish the brain to support natural deep sleep, focus, and creativity with no artificial melatonin or stimulants. The company's products, Delta and Gamma, are 100% safe and contain no preservatives, gluten, added sugar, or animal products. BrainLuxury was founded in 2020 by Ivica Djurdjevic, Hermann Schützinger, and Axel Bouchon. Hermann Schützinger has been the CEO since 2020. | Vorsitzender | 01.01.2020 | 01.01.2023 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | 01.01.2023 | |
Gründer | 01.01.2020 | 01.01.2023 | |
BRII BIOSCIENCES LIMITED | Direktor/Vorstandsmitglied | 22.06.2021 | 30.09.2022 |
BAYER AG | Corporate Officer/Principal | 01.01.2015 | 01.01.2019 |
MODERNA, INC. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Axel Bouchon
Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Deutschland | 4 |
Cayman Islands | 2 |
Operativ
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Chairman | 2 |
Sektoral
Health Technology | 5 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BAYER AG | Health Technology |
MODERNA, INC. | Health Technology |
BRII BIOSCIENCES LIMITED | Commercial Services |
Private Unternehmen | 7 |
---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Moderne Capital LLC
Moderne Capital LLC Investment ManagersFinance Moderne Capital LLC (Moderne Ventures) is a venture capital firm founded in 2015 by Constance Freedman. The firm is headquartered in Chicago, Illinois. | Finance |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
Brain Games Corp. | |
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology BrainLuxury, Inc. is a company that provides natural alternatives for deep sleep and focus, driven by science. The company is based in New York, NY. The company's mission is to nourish the brain to support natural deep sleep, focus, and creativity with no artificial melatonin or stimulants. The company's products, Delta and Gamma, are 100% safe and contain no preservatives, gluten, added sugar, or animal products. BrainLuxury was founded in 2020 by Ivica Djurdjevic, Hermann Schützinger, and Axel Bouchon. Hermann Schützinger has been the CEO since 2020. | Health Technology |
AMLOne UG (haftungsbeschränkt) | |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Matter Neuroscience is an American company that develops mobile applications for neurological reward systems. The private company was founded by Benjamin Goldhirsh and Axel Bouchon, with Axel Bouchon serving as the CEO since incorporation. | Technology Services |
- Börse
- Insiders
- Axel Bouchon
- Erfahrung